The weekly litigation news digest is live. Subscribe now

IP Verse

Alnylam Pharmaceuticals competitive analysis

Loading summary...

Latest oppositions filed by Alnylam Pharmaceuticals

Explore patent oppositions filed by Alnylam Pharmaceuticals against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP2978451	Compositions And Methods For Increasing The Serum Half-Life Of A Therapeutic Agent Targeting Complement C5	ALEXION PHARMACEUTICALS	Aug 27, 2020
EP3222724	Further Novel Forms Of Interfering Rna Molecules	SILENCE THERAPEUTICS	Oct 31, 2018
EP1857547	Further Novel Forms Of Interfering Rna Molecules	ATUGEN	Aug 17, 2018
EP2258847	Futher Novel Forms Of Interfering Rna Molecules	SILENCE THERAPEUTICS	Oct 19, 2017

Latest patents of Alnylam Pharmaceuticals opposed by its competitors

Explore Alnylam Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025

Patent Number	Publication Date	Title	Total Oppositions
EP3366775	Aug 6, 2025	Modified Rnai Agents	1
EP3656860	Apr 20, 2022	Angiopoietin-Like 3 (Angptl3) Irna Compositions And Methods Of Use Thereof	1
EP3105331	Jun 23, 2021	Ketohexokinase (Khk) Irna Compositions And Methods Of Use Thereof	1
EP2723758	Jun 20, 2018	Angiopoietin-Like 3 (Angptl3) Irna Compostions And Methods Of Use Thereof	1

Latest PTAB cases involving Alnylam Pharmaceuticals

Discover the latest PTAB cases involving Alnylam Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 16, 2025

Proceeding Number	Filing Date	Petitioner	Respondent	Status
Get alerts for PTAB Cases involving Alnylam Pharmaceuticals
PGR2018-00088	Jul 17, 2018	ALNYLAM PHARMACEUTICALS	SILENCE THERAPEUTICS	Terminated-Settled
PGR2018-00089	Jul 17, 2018	ALNYLAM PHARMACEUTICALS	SILENCE THERAPEUTICS	Terminated-Settled
PGR2018-00075	Jul 9, 2018	ALNYLAM PHARMACEUTICALS	SILENCE THERAPEUTICS	Terminated-Settled
PGR2018-00067	Jun 11, 2018	ALNYLAM PHARMACEUTICALS	SILENCE THERAPEUTICS	Terminated-Settled
PGR2018-00059	Apr 2, 2018	ALNYLAM PHARMACEUTICALS	SILENCE THERAPEUTICS	Terminated-Settled

Peer Comparison New

IP litigation analysis comparing Alnylam Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
ALNYLAM PHARMACEUTICALS	4	4	5	-
GRUNECKER PATENT UND RECHTSANWALTE PARTG MBB	48	-	-	-
SILENCE THERAPEUTICS	2	8	-	5